Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat, SD-101, and Radiotherapy in Advanced Solid Tumors and Lymphoma
NCT03322384Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Jan 2018
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in solid tumor, lymphoma, sponsored by University of California, Davis. Started Jan 2018; status: completed.
02
Drugs
epacadostat
03
Conditions
solid tumorlymphoma
Beyond the preview
Go deeper on NCT03322384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03322384.